Association of the long fluoroscopy time with factors in contemporary primary percutaneous coronary interventions

Satoshi Asada1, Kenichi Sakakura1, Yousuke Taniguchi1

  • 1Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Shimotsuke, Japan.

Plos One
|August 11, 2020
PubMed

Insights

Longer fluoroscopy times in primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) are linked to complex lesion characteristics. Diffuse long lesions, tortuosity, and calcification increase fluoroscopy time, highlighting areas for improved reperfusion strategies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging

Background:

  • Long fluoroscopy times during primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) may indicate delayed reperfusion.
  • Identifying lesion characteristics associated with prolonged fluoroscopy is crucial for optimizing PCI procedures.

Purpose of the Study:

  • To investigate the association between clinical factors and long fluoroscopy times in primary PCI.
  • To determine which specific lesion characteristics contribute to extended fluoroscopy duration.

Main Methods:

  • A cohort of 539 patients undergoing primary PCI was analyzed.
  • Patients were categorized into conventional (n=434) and long fluoroscopy-time (n=105) groups based on quintiles.
  • Univariate and multivariate logistic regression analyses were employed to identify significant associations.

Main Results:

  • Diabetes mellitus, hemodialysis, and prior coronary artery bypass grafting (CABG) were associated with longer fluoroscopy times.
  • Complex lesion features including lesion length (OR 1.751), moderate-excessive tortuosity (OR 4.006), and moderate to severe calcification (OR 1.865) were significantly linked to prolonged fluoroscopy.
  • These associations remained significant in multivariable analysis.

Conclusions:

  • Diffuse long lesions, tortuosity, and moderate to severe calcification are key factors associated with extended fluoroscopy times in primary PCI for STEMI.
  • Addressing these complex lesion characteristics is essential for reducing reperfusion times and improving outcomes in primary PCI.
  • These findings emphasize the need for tailored approaches in managing complex coronary lesions during primary PCI.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
725
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
417
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
161
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
122
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
395
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
136